window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

mRNA

  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Partnerships & Funding,Technology and platforms

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    August 5, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Clinical Development,Drug Development,Technology and platforms

    Solvias expands US cGMP testing capabilities with RTP center phase 2 build-out

    Solvias has achieved Current Good Manufacturing Practice (cGMP) readiness at [...]

    July 22, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Drug Development,Technology and platforms

    Elegen and Nutcracker pilot cell-free RNA manufacturing for personalized cancer therapeutics

    Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

    July 15, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding

    Ethris signs strategic collaboration with Thermo Fisher Scientific to provide access to mRNA technology platforms

    Partnership further validates Ethris’ novel technology platform based on stabilized [...]

    June 16, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Delivery & Formulation

    N4 Pharma reports positive in vivo results from oral IBD gene therapy study using Nuvec

    UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

    June 8, 2025
  • Clinical Trials,Drug Development,Patient Centricity,Precision medicine,Technology and platforms

    START’s early-phase network supports first-in-human cancer immunotherapy trial targeting solid tumors

    The START Center for Cancer Research has dosed the first [...]

    May 19, 2025
  • Drug Delivery & Formulation,Partnerships & Funding

    Roquette completes IFF Pharma Solutions acquisition, strengthening position in global excipients market

    Roquette has announced the successful completion of its acquisition of [...]

    May 1, 2025
  • Drug Delivery & Formulation

    Ethris and Lonza collaborate to develop spray-dried mRNA vaccines for respiratory disease prevention

    April 15, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top